SCHEMBL22051116

SCHEMBL22051116

Nc1ccc2cc3c(cc2c1)C(Cc1ccc2ccccc2c1)(c1ccccc1)c1cc2cc(N)ccc2cc1O3

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
CYP3A4 P08684 2/20 0.42
HSD17B10 Q99714 2/20 0.42
ALOX15 P16050 1/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
HBB P68871 1/20 0.41
HIF1A Q16665 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
KDM1A O60341 2/20 0.38
MAOA P21397 2/20 0.38
MAOB P27338 2/20 0.38
CYP1A2 P05177 2/20 0.33
CYP2A6 P11509 1/20 0.33
HCAR2 Q8TDS4 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22050405 0.91 ALDH1A1 (0.40) ALDH1A1CYP3A4HSD17B10ALOX15CASP1
SCHEMBL22050400 0.84 ALDH1A1 (0.44) ALDH1A1CYP3A4HSD17B10ALOX15CASP1
SCHEMBL22051115 0.78 ALDH1A1 (0.47) ALDH1A1CYP3A4HSD17B10ALOX15CASP1
SCHEMBL22050397 0.76 ALDH1A1 (0.44) ALDH1A1CYP3A4HSD17B10ALOX15CASP1
SCHEMBL22050706 0.75 ALDH1A1 (0.42) ALDH1A1CYP3A4HSD17B10ALOX15CASP1
SCHEMBL22051117 0.73 ALDH1A1 (0.41) ALDH1A1CYP3A4HSD17B10ALOX15CASP1
SCHEMBL22051874 0.70 ALDH1A1 (0.46) ALDH1A1CYP3A4HSD17B10ALOX15CASP1
SCHEMBL22050399 0.69 ALDH1A1 (0.40) ALDH1A1CYP3A4HSD17B10ALOX15CASP1
SCHEMBL19818082 0.68 HSP90AA1 (0.41) KDM1AMAOAMAOBCYP1A2HCAR2
SCHEMBL22051893 0.68 ALDH1A1 (0.42) ALDH1A1CYP3A4HSD17B10ALOX15CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200172470-A1 NOVEL (POLY)AMINE COMPOUND, RESIN AND CURED PRODUCT MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2020-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200172470-A1 NOVEL (POLY)AMINE COMPOUND, RESIN AND CURED PRODUCT PAM, CBR1, KDM1A ALDH1A1 276/4885CYP3A4 1300/4885HSD17B10 1943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.